|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 707351-707375 of 2347236 (93890 Page(s) Totally)
<< < 28290 28291 28292 28293 28294 28295 28296 28297 28298 28299 > >>
View [10|25|50] records per page
| 國立彰化師範大學 |
1997 |
Ramanujan’s Evaluations of Rogers–Ramanujan Type Continued Fractions at Primitive Roots of Unity
|
Huang, Sen-Shan |
| 國家衛生研究院 |
2021-10-25 |
RamAp, an efflux pump regulator carried by an IncHI2 plasmid
|
Hong, YP;Wang, YW;Chen, BH;Song, HY;Chiou, CS;Chen, YT |
| 臺北醫學大學 |
2000 |
Ramazzini與工作者的健康
|
林佳谷 |
| 臺北醫學大學 |
2000 |
Ramazzini與工作者的健康
|
林佳谷 |
| 高雄醫學大學 |
2006 |
Ramipril口腔快速崩散錠之處方研究
|
陳雅娟; Chen, Ya-Chuan |
| 高雄醫學大學 |
2005 |
Ramipril口腔快速崩散錠之處方研究
|
陳雅娟;羅永光;蔡東榮;詹道明 |
| 高雄醫學大學 |
2003 |
Ramipril膠囊之處方研究
|
陳九如;羅永光;吳銘峻;蔡東榮;詹道明 |
| 高雄醫學大學 |
2004 |
Ramipril膠囊之處方研究
|
羅永光;陳九如;吳銘峻;蔡東榮;詹道明 |
| 臺大學術典藏 |
2021-08-05T02:41:32Z |
Ramp-creep ultrasound viscoelastography for measuring viscoelastic parameters of materials
|
Lin C.-Y.; Lin C.-Y.; CHE-YU LIN |
| 國立交通大學 |
2014-12-12T01:50:49Z |
Ramp-up階段新舊製程混製生產時的投料批量決策模式
|
陳俊穎; Chen, Chun-Ying; 許錫美; Hsu, Hsi-Mei |
| 國立臺灣大學 |
2001 |
Ramsay Hunt Syndrome on a Pregnant Woman-a Case Report
|
楊怡和; YOUNG, YI-HO |
| 臺北醫學大學 |
2013 |
Ramsay Hunt Syndrome with Vocal Fold Paralysis
|
HH, Lee;CW, Yeh;SH, Hung |
| 臺北醫學大學 |
2013 |
Ramsay Hunt Syndrome with Vocal Fold Paralysis
|
Lee, HH;Yeh, CW;Hung, SH |
| 臺北醫學大學 |
2014 |
Ramsay Hunt syndrome with vocal fold paralysis
|
Lee, Hsun-Hua;Yeh, Chi-Wei;Hung, Shih-Han |
| 高雄醫學大學 |
2008 |
Ramsay Hunt syndrome病人之內耳功能探討
|
王遜模;何坤瑤;蔡世盟 |
| 國立中山大學 |
2008-06-25 |
Ramsay 模糊神經網路之研究
|
吳宗翰 |
| 國立中山大學 |
1995 |
Ramsey families which exclude a graph
|
V. Rodl;N. Sauer;X. Zhu |
| 國立政治大學 |
2011 |
Ramsey Taxes Meet Price Rigidity
|
Yang, C. C.;Teo, Wing Leong |
| 國立成功大學 |
2015-09 |
Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment
|
Chau, I.; Park, J. O.; Ryoo, B. Y.; Yen, C. J.; Poon, R.; Pastorelli, D.; Blanc, J. F.; Kudo, M.; Pfiffer, T. F.; Hatano, E.; Chung, H. C.; Kubackova, K.; Phelip, J. M.; Brandi, G.; Ohkawa, S.; Li, C. P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. |
| 國家衛生研究院 |
2020-02 |
Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study
|
Valle, JW;Bai, LY;Orlova, R;Van Cutsem, E;Alfonso, JA;Chen, LT;Obermannova, R;Ettrich, TJ;Chen, JS;Wasan, HS;Denlinger, CS;Vogel, A;He, AR;Bousmans, N;Girvan, AC;Zhang, W;Walgren, RA;Carlesi, R;Oh, DY |
| 國立成功大學 |
2019 |
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Zhu, A.X.;Kang, Y.-K.;Yen, C.-J.;Finn, R.S.;Galle, P.R.;Llovet, J.M.;Assenat, E.;Brandi, G.;Pracht, M.;Lim, H.Y.;Rau, K.-M.;Motomura, K.;Ohno, I.;Merle, P.;Daniele, B.;Shin, D.B.;Gerken, Gerken G.;Borg, C.;Hiriart, J.-B.;Okusaka, T.;Morimoto, Morimoto M.;Hsu, Y.;Abada, P.B.;Kudo, M.;investigators, REACH-2 study |
| 臺大學術典藏 |
2022-09-15T01:08:52Z |
Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
|
Bang Y.-J.; Golan T.; Dahan L.; Fu S.; Moreno V.; Park K.; Geva R.; De Braud F.; Wainberg Z.A.; Reck M.; Goff L.; Laing N.; Mi G.; Oliveira J.M.; Wasserstrom H.; Chia-Chi Lin |
| 國立成功大學 |
2022 |
Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study: RAM/PL + BSC for advanced HCC
|
Shao, G.;Bai, Y.;Yuan, X.;Chen, X.;Gu, S.;Gu, K.;Hu, C.;Liang, H.;Guo, Y.;Wang, J.;Yen, C.-J.;Lee, V.H.-F.;Wang, C.;Widau, R.C.;Zhang, W.;Liu, J.;Zhang, Q.;Qin, S. |
| 國立成功大學 |
2021 |
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma and elevated alpha-fetoprotein: Pooled results from two phase 3 studies (REACH and REACH-2)
|
Kudo, M.;Finn, R.S.;Morimoto, Morimoto M.;Rau, K.-M.;Ikeda, M.;Yen, C.-J.;Galle, P.R.;Llovet, J.M.;Daniele, B.;Lim, H.Y.;McIlwain, D.W.;Yoshikawa, R.;Nakamura, K.;Liang, K.;Wang, C.;Abada, P.;Widau, R.C.;Zhu, A.X. |
| 臺大學術典藏 |
2021-01-18T09:12:07Z |
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY
|
Nishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B.; Chiu, Chao Hua; Yoh, Kiyotaka; Imamura, Fumio; Park, Keunchil; JIN-YUAN SHIH; Visseren-Grul, Carla; Frimodt-Moller, Bente; Zimmermann, Annamaria; Homma, Gosuke; Enatsu, Sotaro; Nakagawa, Kazuhiko |
Showing items 707351-707375 of 2347236 (93890 Page(s) Totally)
<< < 28290 28291 28292 28293 28294 28295 28296 28297 28298 28299 > >>
View [10|25|50] records per page
|
